Literature DB >> 21369706

Cell surface heat shock protein 90 modulates prostate cancer cell adhesion and invasion through the integrin-β1/focal adhesion kinase/c-Src signaling pathway.

Xueguang Liu1, Zuoqin Yan, Liang Huang, Muyi Guo, Zhigang Zhang, Changan Guo.   

Abstract

Heat shock protein (Hsp) 90 is a molecular chaperone that maintains the active conformation and function of numerous client oncoproteins in cancer cells. Hsp90 has also been detected on the plasma membrane of cells, and its expression has been suggested to correlate with metastatic potential. We studied the PC3 cell line, which is a highly invasive human prostate cancer cell line, and confirmed that Hsp90 is present on the cell surface of PC3 cells. Interestingly, cell surface Hsp90 was also specifically localized at the leading edge of migrating cells. By using a specific antibody that inhibited cell surface Hsp90, adhesion and invasion of PC3 cells were significantly suppressed in vitro. Concomitantly with these findings, we demonstrated that the inhibition of cell surface Hsp90 not only inhibited the FN-dependent association between FAK, c-Src and integrin β1, but also significantly inhibited the phosphorylation of FAK and c-Src, as well as their downstream targets paxillin and p130Cas. Additionally, the Hsp90 antibody reversed cell invasion stimulated by overexpression of FAK. These data indicate that cell surface Hsp90 is involved in prostate cancer cell invasion through the integrin β1/FAK/c-Src signaling pathway. Our study provides new insights into the mechanisms of cell surface Hsp90 in cancer invasion. These results suggest that molecular targeting of cell surface Hsp90 may therefore be a novel target for the effective treatment of metastatic prostate cancer.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21369706     DOI: 10.3892/or.2011.1202

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  14 in total

1.  HSP90 and HSP70 proteins are essential for stabilization and activation of WASF3 metastasis-promoting protein.

Authors:  Yong Teng; Lambert Ngoka; Yun Mei; Leslieann Lesoon; John K Cowell
Journal:  J Biol Chem       Date:  2012-02-07       Impact factor: 5.157

2.  Co-chaperones TIMP2 and AHA1 Competitively Regulate Extracellular HSP90:Client MMP2 Activity and Matrix Proteolysis.

Authors:  Alexander J Baker-Williams; Fiza Hashmi; Marek A Budzyński; Mark R Woodford; Stephanie Gleicher; Samu V Himanen; Alan M Makedon; Derek Friedman; Stephanie Cortes; Sara Namek; William G Stetler-Stevenson; Gennady Bratslavsky; Alaji Bah; Mehdi Mollapour; Lea Sistonen; Dimitra Bourboulia
Journal:  Cell Rep       Date:  2019-08-13       Impact factor: 9.423

3.  Involvement of cell surface 90 kDa heat shock protein (HSP90) in pattern recognition by human monocyte-derived macrophages.

Authors:  Małgorzata Bzowska; Anna Nogieć; Krystian Bania; Magdalena Zygmunt; Mirosław Zarębski; Jerzy Dobrucki; Krzysztof Guzik
Journal:  J Leukoc Biol       Date:  2017-05-26       Impact factor: 4.962

4.  Heat shock protein 90β stabilizes focal adhesion kinase and enhances cell migration and invasion in breast cancer cells.

Authors:  Xiangyang Xiong; Yao Wang; Chengmei Liu; Quqin Lu; Tao Liu; Guoan Chen; Hai Rao; Shiwen Luo
Journal:  Exp Cell Res       Date:  2014-05-28       Impact factor: 3.905

Review 5.  Endoplasmic reticulum chaperones and their roles in the immunogenicity of cancer vaccines.

Authors:  Michael W Graner; Kevin O Lillehei; Emmanuel Katsanis
Journal:  Front Oncol       Date:  2015-01-06       Impact factor: 6.244

6.  Targeting the testis-specific heat-shock protein 70-2 (HSP70-2) reduces cellular growth, migration, and invasion in renal cell carcinoma cells.

Authors:  Swarnendra Singh; Anil Suri
Journal:  Tumour Biol       Date:  2014-09-12

7.  Screening of multiple myeloma by polyclonal rabbit anti-human plasmacytoma cell immunoglobulin.

Authors:  Bo Mu; Huan Zhang; Xiaoming Cai; Junbao Yang; Yuewu Shen; Baofeng Chen; Suhua Liang
Journal:  PLoS One       Date:  2013-04-01       Impact factor: 3.240

8.  Patient-derived heavy chain antibody targets cell surface HSP90 on breast tumors.

Authors:  Charan V Devarakonda; Daniel Kita; Kathryn N Phoenix; Kevin P Claffey
Journal:  BMC Cancer       Date:  2015-09-03       Impact factor: 4.430

Review 9.  The involvement of JAK-STAT3 in cell motility, invasion, and metastasis.

Authors:  Yong Teng; James L Ross; John K Cowell
Journal:  JAKSTAT       Date:  2014-02-20

10.  Hsp90 binds directly to fibronectin (FN) and inhibition reduces the extracellular fibronectin matrix in breast cancer cells.

Authors:  Morgan C Hunter; Kyle L O'Hagan; Amy Kenyon; Karim C H Dhanani; Earl Prinsloo; Adrienne L Edkins
Journal:  PLoS One       Date:  2014-01-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.